156 related articles for article (PubMed ID: 18575193)
1. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
Kamoto K; Aberle-Grasse J;
Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
4. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
5. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
[TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
[TBL] [Abstract][Full Text] [Related]
8. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
[TBL] [Abstract][Full Text] [Related]
9. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
10. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
[TBL] [Abstract][Full Text] [Related]
11. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
[TBL] [Abstract][Full Text] [Related]
13. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
[TBL] [Abstract][Full Text] [Related]
14. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y
Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
[TBL] [Abstract][Full Text] [Related]
16. [The introduction of antiretroviral therapy in Malawi].
Zijlstra EE; van Oosterhout JJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
[TBL] [Abstract][Full Text] [Related]
17. Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.
Daoni E; Kitur U; Parunga A; Ndenzako F; Lloyd A; Yu D
Clin Infect Dis; 2012 May; 54 Suppl 4():S303-5. PubMed ID: 22544192
[TBL] [Abstract][Full Text] [Related]
18. Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
Ma Y; Zhang F; Li H; Wu H; Zhang J; Ding Y; Zhao D; Fang H; Zhou S; Liu Z; Zhang L; Osborne C; Seguy N; Zhao Y
Clin Infect Dis; 2012 May; 54 Suppl 4():S300-2. PubMed ID: 22544191
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687
[TBL] [Abstract][Full Text] [Related]
20. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]